{"id":855,"date":"2024-11-24T11:39:35","date_gmt":"2024-11-24T11:39:35","guid":{"rendered":"http:\/\/scientificadvances.org\/?p=855"},"modified":"2024-11-24T11:39:35","modified_gmt":"2024-11-24T11:39:35","slug":"the-kd-value-for-meth-decided-with-the-5050-combination-was-7","status":"publish","type":"post","link":"https:\/\/scientificadvances.org\/?p=855","title":{"rendered":"\ufeffThe KD value for METH decided with the 50:50 combination was 7"},"content":{"rendered":"

\ufeffThe KD value for METH decided with the 50:50 combination was 7.6?nM. concentrations (at 5?hrs) were measured after each METH challenge. MAb7F9-mAb4G9 treatment significantly reduced the duration of locomotor activity after 6 of the 7 METH doses (anti-METH mAb binding over time. We hypothesized that a 50:50 mixture of 2 different high affinity anti-METH mAbs with different specificities for METH-like molecules could increase efficacy over previously reported single mAb therapy.10 To test this hypothesis, we administered a mixture of equal parts mAb7F9 and mAb4G9 to male Sprague-Dawley rats (METH KD = 7.7 and 16?nM, respectively; amphetamine [AMP] KD = 270?nM and 110?nM).11,12 Over a one-month period, we used METH-induced behavioral and METH concentration measures to assess the efficacy of the anti-METH mAb combination in clinically relevant scenarios of chronic mAb treatment for METH dependency. As part of this assessment, we Fluorocurarine chloride also decided the potential effects of missing or stopping mAb treatments, a likely scenario for patients undergoing treatment for METH dependency. Finally, we compared the mAb7F9-mAb4G9 treatment to previously reported results of mAb7F9 monotherapy10 by assessing how constantly each treatment affected the period of action of METH-induced locomotor activity during and after the mAb dosing regimens, as well as comparing each treatments’ effect on METH and AMP concentrations. This comparison showed the combination mAb7F9-mAb4G9 therapy was much Rabbit polyclonal to PLS3<\/a> less effective than treatment with mAb7F9 alone. Additionally, the results exhibited the importance of affinity and specificity as crucial mAb properties for effective, long-lasting anti-METH mAb function. Results MAb7F9-mAb4G9 dissociation constants (KD) for METH and AMP We characterized the combined KD of the 50:50 mixture of mAb7F9 and mAb4G9. The KD value for METH decided with the 50:50 combination was 7.6?nM. This was essentially the same value as previously reported for METH binding to mAb7F9 (KD = of 7.7?nM), but Fluorocurarine chloride was different from the 16?nM KD value for mAb4G9.11,12 The Ki value for AMP binding with the 50:50 mixture was 145?nM. This was similar to the reported AMP binding with mAb4G9 (KD = 110?nM) rather than the 270?nM AMP KD value reported for mAb7F9.12 Because both antibodies had higher affinity for METH than AMP, Ki values of AMP binding determined using a [3H]-METH radioligand are Fluorocurarine chloride higher than KD values determined using a [3H]-AMP radioligand. METH-induced locomotor activity with increasing METH doses The effects of METH dose on locomotor response were determined to establish a model for assessing mAb effects on METH-induced behavior. The distance traveled vs time after METH administration for 4 different METH doses is shown in Physique?1A. There were no significant differences (values of and METH Fluorocurarine chloride binding, leading to benefits in therapeutic efficacy. Indeed, the affinity measurement of the 50:50?mAb combination was reflective of the of the relatively higher METH affinity of mAb7F9 and the relatively higher AMP affinity of mAb4G9. METH-induced locomotor activity was a main measure of chronic anti-METH mAb effects. Drugs that inhibit METH-induced locomotor activity have also been shown to inhibit METH effects in conditioned place preference15 and self-administration16 assays. During the development of this model of chronic treatment, we had to consider the effects of METH-induced stereotypy on horizontal motion. After high doses of stimulant, the effects are predominately repetitive stereotypic actions with limited Fluorocurarine chloride<\/a> horizontal motion. Over time this transitions into predominately horizontal motion, which is the predominate locomotor activity found with lower doses of METH.17 In addition, stereotypy-induced suppression of stimulant-induced locomotion occurs with repeated dosing (even at low doses).18 This can complicate the analysis of mAb-induced effects on each METH dose, especially in studies in which METH is repeatedly administered. To better understand the implication of these changes for our experiments, we analyzed locomotor effects in a control group of rats following 4 escalating METH doses (Fig.?1). Surprisingly, despite the log difference between the 0.56 and 5.6?mg\/kg METH.<\/p>\n","protected":false},"excerpt":{"rendered":"

\ufeffThe KD value for METH decided with the 50:50 combination was 7.6?nM. concentrations (at 5?hrs) were measured after each METH challenge. MAb7F9-mAb4G9 treatment significantly reduced the duration of locomotor activity after 6 of the 7 METH doses (anti-METH mAb binding over time. We hypothesized that a 50:50 mixture of 2 different high affinity anti-METH mAbs […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[32],"tags":[],"class_list":["post-855","post","type-post","status-publish","format-standard","hentry","category-imidazoline-i3-receptors"],"_links":{"self":[{"href":"https:\/\/scientificadvances.org\/index.php?rest_route=\/wp\/v2\/posts\/855","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/scientificadvances.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/scientificadvances.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/scientificadvances.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/scientificadvances.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=855"}],"version-history":[{"count":1,"href":"https:\/\/scientificadvances.org\/index.php?rest_route=\/wp\/v2\/posts\/855\/revisions"}],"predecessor-version":[{"id":856,"href":"https:\/\/scientificadvances.org\/index.php?rest_route=\/wp\/v2\/posts\/855\/revisions\/856"}],"wp:attachment":[{"href":"https:\/\/scientificadvances.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=855"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/scientificadvances.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=855"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/scientificadvances.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=855"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}